Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

FDA OKs Drug to Treat Constipation

Amitiza Cleared to Treat Constipation Not Caused by Disease or Medication
WebMD Health News
Reviewed by Louise Chang, MD

Feb. 1, 2006 -- The FDA has approved Amitiza, the first drug of its chemical type, to treat chronic constipation in adults.

Amitiza will be available as capsules for use by adults to treat chronic constipation that doesn't have a known cause (such as other diseases or use of medications).

Chronic constipation is generally defined as infrequent and difficult passage of stool. One of America's most common disorders, chronic constipation is more often seen in women and in adults aged 65 and older. Symptoms are abdominal pain and discomfort, bloating, straining, and hard stools.

Amitiza works by increasing the secretion of intestinal fluid secretion, which helps ease stool passage and constipation symptoms. The drug should be taken twice daily with food. Doctors and patients should periodically assess the need for continued treatment, states an FDA news release.

Amitiza's Approval

The FDA based its decision to approve Amitiza on the results from two clinical trials. When the trial began, participants averaged less than three spontaneous bowel movements per week; they had had constipation symptoms for at least the last six months.

The studies showed that patients treated with Amitiza had more frequent bowel movements in the first week than those taking a fake drug (placebo). In both studies, similar results were seen for the next three weeks of treatment.

In addition, three long-term studies showed that Amitiza decreased constipation severity, abdominal bloating, and discomfort over six to 12 months of use.

The most common adverse events reported in the trials included headache, nausea, diarrhea, abdominal pain, and distension. Whether these events are related to the drug is not yet known.

Amitiza is marketed by Sucampo Pharmaceuticals, Inc., of Bethesda, Md., and by Takeda Pharmaceuticals America of Lincolnshire, Ill.

Today on WebMD

man holding his stomach
Get the facts on common problems.
blueberries in a palm
Best and worst foods.
woman shopping
Learn what foods to avoid.
fresh and dried plums
Will it help constipation?
diverticuliltis illustration
couple eating at cafe
sick child
Woman blowing bubble gum

Send yourself a link to download the app.

Loading ...

Please wait...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.

Woman with crohns in pain
Woman with stomach pain
diet for diverticulitis
what causes diarrhea